名稱 | mMRGPRB2/Ga15/HEK293 |
型號(hào) | CBP71341 |
報(bào)價(jià) | ![]() |
特點(diǎn) | mMRGPRB2/Ga15/HEK293 凍存條件:90% FBS+10% DMSO |
產(chǎn)品搜索
相關(guān)文章
- 腫瘤細(xì)胞內(nèi)的膠原蛋白有哪些作用?
- NGS檢測(cè)血液腫瘤基因
- GLP1R藥靶篩選模型應(yīng)用展示
- 從諾輝財(cái)報(bào)看甲基化市場(chǎng),科佰生物助力甲基化標(biāo)準(zhǔn)品的開發(fā)
- 為您解讀ATCC細(xì)胞株的可追溯性
- ATCC細(xì)胞系的細(xì)胞培養(yǎng)步驟
- Canine IL-31細(xì)胞篩選模型
- *針對(duì)肝癌的PD-1抗體獲FDA批準(zhǔn),國(guó)產(chǎn)PD-1抗體進(jìn)入三期
- 肥胖與腫瘤治療新星靶點(diǎn)——GDF15-GFRAL
- 針對(duì)ctDNA的MRD檢測(cè),你參與了嗎?
聯(lián)系我們
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > GPCR細(xì)胞株 > CBP71341mMRGPRB2/Ga15/HEK293

- 詳細(xì)內(nèi)容
CBP71341 | |
I. Background | |
Mast cell-specific receptor for basic secretagogues, i.e. cationic amphiphilic drugs, as well as endo- or exogenous peptides, consisting of a basic head group and a hydrophobic core. Recognizes and binds small molecules containing a cyclized tetrahydroisoquinoline (THIQ), such as non-steroidal neuromuscular blocking drugs (NMBDs), including tubocurarine and atracurium. In response to these compounds, mediates pseudo-allergic reactions characterized by histamine release, inflammation and airway contraction. | |
II. Introduction | |
Host Cell: | HEK293 |
Stability: | 20 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Freeze Medium: | 90% FBS+10% DMSO |
Culture Medium: | DMEM+10%FBS+400ug/ml G418+ 100 μg/ml Hygromycin B |
Mycoplasma Status: | Negative |
Storage: | Liquid nitrogen immediately upon delivery |
Application(s): | Functional assay for mMRGPRB2 receptor |
Transducer: | Gi |
Ⅲ. Description of Host Cell Line | |
Organism: | Human |
Tissue: | kidney |
Morphology: | Epithelial |
Growth Properties: | Adherent |
Ⅳ. Representative Data | |
Figure 1. mMRGPRB2/Ga15/HEK293, the EC50 was 1.47μg/ml. |